These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1063 related items for PubMed ID: 16510604
1. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Cancer Res; 2006 Mar 01; 66(5):2815-25. PubMed ID: 16510604 [Abstract] [Full Text] [Related]
11. Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events. Sirotnak FM, She Y, Khokhar NZ, Hayes P, Gerald W, Scher HI. Mol Carcinog; 2004 Nov 01; 41(3):150-63. PubMed ID: 15390081 [Abstract] [Full Text] [Related]
14. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN, Schröder FH. BJU Int; 2009 Aug 01; 104(4):438-48. PubMed ID: 19558559 [Abstract] [Full Text] [Related]
16. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V, Tchernof A. J Endocrinol; 2006 Dec 01; 191(3):637-49. PubMed ID: 17170221 [Abstract] [Full Text] [Related]
17. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Latil A, Bièche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. Cancer Res; 2001 Mar 01; 61(5):1919-26. PubMed ID: 11280747 [Abstract] [Full Text] [Related]